Clinical Trial Update: Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the addition of FOLFIRI after progression on encorafenib plus cetuximab in patients with BRAF V600E-mutated metastatic colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Encorafenib (encorafenib)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Colorectal Carcinoma, Colorectal Neoplasms | Phase 2 | Status: RECRUITING